Literature DB >> 3516475

Reduction of urinary protein and prostaglandin E2 excretion in the nephrotic syndrome by non-steroidal anti-inflammatory drugs.

R Vriesendorp, D de Zeeuw, P E de Jong, A J Donker, J J Pratt, G K van der Hem.   

Abstract

Seven salt depleted patients with the idiopathic nephrotic syndrome were treated with various non-steroidal anti-inflammatory drugs. Indomethacin, diclofenac-sodium and flurbiprofen decreased proteinuria, glomerular filtration rate, plasma renin activity and renal prostaglandin E2 excretion by 59%, 19%, 55% and 68% respectively. Sulindac induced no major changes in proteinuria, glomerular filtration rate, plasma renin activity and renal prostaglandin E2 excretion. The relative change in proteinuria and glomerular filtration rate during non-steroidal anti-inflammatory drug treatment correlated strongly with that of the renal prostaglandin E2 excretion (r = 0.89 and r = 0.70, respectively p less than 0.05). It is likely that the anti-proteinuric effect of non-steroidal anti-inflammatory drugs is dependent on their potency to inhibit renal prostaglandin synthesis and it is suggested that this effect is mediated by lowering transcapillary glomerular hydraulic pressure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516475

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Recurrence of focal glomerulosclerosis despite cyclosporin treatment after renal transplantation.

Authors:  Y Pirson; J P Squifflet; E Marbaix; G P Alexandre; C van Ypersele de Strihou
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

Review 2.  Clinical pharmacokinetics of sulindac. A dynamic old drug.

Authors:  N M Davies; M S Watson
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

Review 3.  Hyperfiltration-associated biomechanical forces in glomerular injury and response: Potential role for eicosanoids.

Authors:  Mukut Sharma; Ram Sharma; Ellen T McCarthy; Virginia J Savin; Tarak Srivastava
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-01-17       Impact factor: 3.072

Review 4.  Prostaglandin inhibitors in the treatment of nephrotic syndrome.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

5.  Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.

Authors:  Martin H de Borst; Ferdau L Nauta; Liffert Vogt; Gozewijn D Laverman; Ron T Gansevoort; Gerjan Navis
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.